David Linetsky Insider Trading $PHR Phreesia, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for David Linetsky.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of David Linetsky. David Linetsky is See Remarks in Phreesia, Inc. ($PHR) and SVP, Life Sciences in Phreesia, Inc. ($PHR).
David Linetsky in Phreesia, Inc.
Trading Symbol: PHRIndustry: SERVICES-BUSINESS SERVICES, NEC [7389]
Position of David Linetsky: SVP, Life Sciences, See Remarks
Holdings: 117,633 shares
Latest Transaction: May 05 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of David Linetsky in Phreesia, Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 05 2021 | PHR | Phreesia, Inc. | Linetsky David | SVP, Life Sciences | Option Exercise | M | 0.84 | 22,755 | 19,114 | 0 | |
May 05 2021 | PHR | Phreesia, Inc. | Linetsky David | SVP, Life Sciences | Option Exercise | M | 2.03 | 22,755 | 46,193 | 0 | |
May 05 2021 | PHR | Phreesia, Inc. | Linetsky David | SVP, Life Sciences | Buy | M | 2.03 | 22,755 | 46,193 | 140,388 | 117.6 K to 140.4 K (+19.34 %) |
May 05 2021 | PHR | Phreesia, Inc. | Linetsky David | SVP, Life Sciences | Buy | M | 0.84 | 22,755 | 19,114 | 117,633 | 94.9 K to 117.6 K (+23.98 %) |
Mar 17 2021 | PHR | Phreesia, Inc. | Linetsky David | SVP, Life Sciences | Sell | S | 61.31 | 300 | 18,393 | 92,580 | 92.9 K to 92.6 K (-0.32 %) |
Mar 17 2021 | PHR | Phreesia, Inc. | Linetsky David | SVP, Life Sciences | Sell | S | 60.62 | 500 | 30,312 | 92,880 | 93.4 K to 92.9 K (-0.54 %) |
Mar 17 2021 | PHR | Phreesia, Inc. | Linetsky David | SVP, Life Sciences | Sell | S | 58.51 | 778 | 45,519 | 93,380 | 94.2 K to 93.4 K (-0.83 %) |
Mar 17 2021 | PHR | Phreesia, Inc. | Linetsky David | SVP, Life Sciences | Sell | S | 61.69 | 6,706 | 413,721 | 94,158 | 100.9 K to 94.2 K (-6.65 %) |
Mar 17 2021 | PHR | Phreesia, Inc. | Linetsky David | SVP, Life Sciences | Sell | S | 61.06 | 41,776 | 2,550,788 | 100,864 | 142.6 K to 100.9 K (-29.29 %) |
Jan 22 2021 | PHR | Phreesia, Inc. | Linetsky David | SVP, Life Sciences | Sell | S | 66.14 | 6,282 | 415,515 | 142,640 | 148.9 K to 142.6 K (-4.22 %) |
Jan 22 2021 | PHR | Phreesia, Inc. | Linetsky David | SVP, Life Sciences | Sell | S | 64.86 | 544 | 35,283 | 148,922 | 149.5 K to 148.9 K (-0.36 %) |
Jan 20 2021 | PHR | Phreesia, Inc. | Linetsky David | SVP, Life Sciences | Sell | S | 64.28 | 5,136 | 330,119 | 149,466 | 154.6 K to 149.5 K (-3.32 %) |
Jan 20 2021 | PHR | Phreesia, Inc. | Linetsky David | SVP, Life Sciences | Payment of Exercise | F | 62.96 | 277 | 17,440 | 154,602 | 154.9 K to 154.6 K (-0.18 %) |
Jan 20 2021 | PHR | Phreesia, Inc. | Linetsky David | SVP, Life Sciences | Payment of Exercise | F | 62.96 | 1,787 | 112,510 | 154,879 | 156.7 K to 154.9 K (-1.14 %) |
Jan 20 2021 | PHR | Phreesia, Inc. | Linetsky David | SVP, Life Sciences | Grant | A | 0.00 | 28,589 | 0 | 156,666 | 128.1 K to 156.7 K (+22.32 %) |
Jul 06 2020 | PHR | Phreesia, Inc. | Linetsky David | SVP, Life Sciences | Option Exercise | M | 4.71 | 1,376 | 6,481 | 20,003 | |
Jul 06 2020 | PHR | Phreesia, Inc. | Linetsky David | SVP, Life Sciences | Sell | S | 28.24 | 4,475 | 126,396 | 131,177 | 135.7 K to 131.2 K (-3.30 %) |
Jul 06 2020 | PHR | Phreesia, Inc. | Linetsky David | SVP, Life Sciences | Buy | M | 4.71 | 1,376 | 6,481 | 135,652 | 134.3 K to 135.7 K (+1.02 %) |
May 11 2020 | PHR | Phreesia, Inc. | Linetsky David | SVP, Life Sciences | Sell | S | 26.00 | 255 | 6,630 | 134,276 | 134.5 K to 134.3 K (-0.19 %) |
May 11 2020 | PHR | Phreesia, Inc. | Linetsky David | SVP, Life Sciences | Sell | S | 26.00 | 255 | 6,630 | 134,276 | 134.5 K to 134.3 K (-0.19 %) |
May 04 2020 | PHR | Phreesia, Inc. | Linetsky David | SVP, Life Sciences | Payment of Exercise | F | 23.67 | 786 | 18,605 | 134,531 | 135.3 K to 134.5 K (-0.58 %) |
May 04 2020 | PHR | Phreesia, Inc. | Linetsky David | SVP, Life Sciences | Grant | A | 0.00 | 1,806 | 0 | 135,317 | 133.5 K to 135.3 K (+1.35 %) |
Apr 29 2020 | PHR | Phreesia, Inc. | Linetsky David | SVP, Life Sciences | Option Exercise | M | 4.71 | 1,376 | 6,481 | 21,379 | |
Apr 29 2020 | PHR | Phreesia, Inc. | Linetsky David | SVP, Life Sciences | Sell | S | 26.00 | 4,220 | 109,720 | 133,511 | 137.7 K to 133.5 K (-3.06 %) |
Apr 29 2020 | PHR | Phreesia, Inc. | Linetsky David | SVP, Life Sciences | Buy | M | 4.71 | 1,376 | 6,481 | 137,731 | 136.4 K to 137.7 K (+1.01 %) |
Mar 17 2020 | PHR | Phreesia, Inc. | Linetsky David | SVP, Life Sciences | Option Exercise | M | 0.84 | 43,234 | 36,317 | 0 | |
Mar 17 2020 | PHR | Phreesia, Inc. | Linetsky David | SVP, Life Sciences | Option Exercise | M | 0.69 | 4,551 | 3,140 | 0 | |
Mar 17 2020 | PHR | Phreesia, Inc. | Linetsky David | SVP, Life Sciences | Option Exercise | M | 0.82 | 2,275 | 1,866 | 0 | |
Mar 17 2020 | PHR | Phreesia, Inc. | Linetsky David | SVP, Life Sciences | Buy | M | 0.84 | 43,234 | 36,317 | 136,355 | 93.1 K to 136.4 K (+46.43 %) |
Mar 17 2020 | PHR | Phreesia, Inc. | Linetsky David | SVP, Life Sciences | Buy | M | 0.69 | 4,551 | 3,140 | 93,121 | 88.6 K to 93.1 K (+5.14 %) |
Mar 17 2020 | PHR | Phreesia, Inc. | Linetsky David | SVP, Life Sciences | Buy | M | 0.82 | 2,275 | 1,866 | 88,570 | 86.3 K to 88.6 K (+2.64 %) |
Feb 20 2020 | PHR | Phreesia, Inc. | Linetsky David | SVP, Life Sciences | Sell | S | 32.93 | 344 | 11,328 | 86,295 | 86.6 K to 86.3 K (-0.40 %) |
Feb 20 2020 | PHR | Phreesia, Inc. | Linetsky David | SVP, Life Sciences | Sell | S | 32.84 | 2,844 | 93,390 | 86,639 | 89.5 K to 86.6 K (-3.18 %) |
Jan 27 2020 | PHR | Phreesia, Inc. | Linetsky David | SVP, Life Sciences | Payment of Exercise | F | 27.83 | 225 | 6,262 | 89,483 | 89.7 K to 89.5 K (-0.25 %) |
Jan 23 2020 | PHR | Phreesia, Inc. | Linetsky David | SVP, Life Sciences | Grant | A | 0.00 | 69,230 | 0 | 89,708 | 20.5 K to 89.7 K (+338.07 %) |
Jan 10 2020 | PHR | Phreesia, Inc. | Linetsky David | See Remarks | Option Exercise | M | 0.73 | 3,413 | 2,491 | 3,413 | |
Jan 10 2020 | PHR | Phreesia, Inc. | Linetsky David | See Remarks | Buy | M | 0.73 | 3,413 | 2,491 | 17,065 | 13.7 K to 17.1 K (+25.00 %) |
Page: 1